Inogen INGN
NASDAQ INGN
$5.27 +0.04 (+0.77%)
As of: Sep 9, 2026 · 3:59 PM EDT

Inogen (INGN) Non-Current Assets (2013 - 2026)

Inogen's (INGN) quarterly Non-Current Assets came in at $91.4 million in Q2 2026, down 16.05% year-over-year from $108.9 million in Q2 2025, and down 4.02% quarter-over-quarter from $95.3 million in Q1 2026.

Analysis

Inogen (INGN) Non-Current Assets (2013 - 2026) Analysis & Trends

Inogen (INGN) has reported Non-Current Assets for 14 consecutive years, with $91.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Assets fell 16.05% year-over-year to $91.4 million in Q2 2026; TTM through Jun 2026 was $390.3 million, a 11.49% decrease from a year earlier, with the FY2025 full-year figure at $100.3 million, down 9.4% from the prior year.
  • Non-Current Assets was $91.4 million for Q2 2026 at Inogen, down from $95.3 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $156.5 million in Q1 2022 and troughed at $91.4 million in Q2 2026.
  • A 5-year average of $115.0 million and a median of $109.8 million in 2024 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets sank 37.38% in 2022 and increased 18.66% in 2023, its largest moves.
  • Over 5 years, Non-Current Assets stood at $100.4 million in 2022, then grew by 18.66% to $119.1 million in 2023, then dropped by 7.05% to $110.7 million in 2024, then dropped by 9.4% to $100.3 million in 2025, then fell by 8.86% to $91.4 million in 2026.
  • The last three Non-Current Assets figures came in at $91.4 million (Q2 2026), $95.3 million (Q1 2026), and $100.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 84.70 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 11.33 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 68.92 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 33.51 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 37.24 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 7.05 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 24.47 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 2.37 Bn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 8.29 Bn
10 Inogen 142.58 Mn 37.04 Mn 43.27 Mn 91.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 91.44 Mn
Mar 31, 2026 95.26 Mn
Dec 31, 2025 100.33 Mn
Sep 30, 2025 103.29 Mn
Jun 30, 2025 108.92 Mn
Mar 31, 2025 107.70 Mn
Dec 31, 2024 110.73 Mn
Sep 30, 2024 113.62 Mn
Jun 30, 2024 114.13 Mn
Mar 31, 2024 116.41 Mn
Dec 31, 2023 119.13 Mn
Sep 30, 2023 118.43 Mn
Jun 30, 2023 105.13 Mn
Mar 31, 2023 102.53 Mn
Dec 31, 2022 100.40 Mn
Sep 30, 2022 151.81 Mn
Jun 30, 2022 154.62 Mn
Mar 31, 2022 156.49 Mn
Dec 31, 2021 160.33 Mn
Sep 30, 2021 177.03 Mn